The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Multiple Myeloma Channel is supported with funding from Sanofi (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2026 | CORAL next-generation AI model for guiding myeloma treatment decisions: insights and next steps
Arjun Rajanna, MSc, Sylvester Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, comments on the current status of CORAL, the next-generation model designed to assist clinicians in making treatment decisions, particularly in the myeloma space, noting that heavy validation is still required. Mr Rajanna highlights the need for more data, computational resources, and collaboration with various stakeholders, including clinicians, pathologists, engineers, and patients, to take the model to the next step and ensure its sustainability. This interview took place during the 2026 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
